I am a 37 year old private trader using propriety technical analysis with more than 17 years experience of investing in markets. And I have 8 years of experience intraday trading of shares of Nasdaq, NYSE and AMEX.
Harvard Apparatus Regenerative Technology (Nasdaq: HART) makes bioengineered organs for life-threatening conditions. Our technology platform is to be used to restore function in the trachea, bronchus and esophagus www.hartregen.com
TRADEPREDICT inputs seasonal historical data, incorporating fundamental and technical aspects to generate the most profitable trades. We are not registered investment advisors and we do not provide trading or investment advice.